Drug intelligence / Profile preview

gualou + xiebai

Development stage
Preclinical
Administration
Oral
01

Overview

Gualou-Xiebai (GLXB) is a classic traditional Chinese herbal combination consisting of Gualou (*Trichosanthes kirilowii* Maxim, dried fruit) and Xiebai (*Allium macrostemon* Bunge, dried bulbs), typically prepared in a 2:1 weight ratio. First documented in the Eastern Han Dynasty treatise 'Jin Kui Yao Lue,' it is used clinically for the treatment of atherosclerosis and cardiovascular diseases. The formulation acts through multiple molecular mechanisms: it inhibits the LOX-1/NCOA4 axis to prevent mitochondrial ferroptosis in vascular smooth muscle cells, suppresses the P2RY12 receptor to activate lipophagy and inhibit foam cell formation, and modulates the PPARγ/LXRα pathways to regulate lipid metabolism and reduce systemic inflammation (lowering IL-6, IL-1β, and TNF-α). Research in ApoE-/- mouse models has demonstrated its efficacy in reducing plaque formation and improving endothelial function.

Other names
Gualou Xiebai DecoctionGualou Xiebai TangTrichosanthes kirilowii and Allium macrostemon combination
02

Targets

OLR1 (Lectin-like oxidized LDL receptor-1)NR1H3 (Liver X receptor beta)NCOA4 (Nuclear receptor coactivator 4)P2Y12 (Purinergic P2Y12 receptor)PPARG (Peroxisome proliferator-activated receptor gamma)NPC1L1 (Niemann-pick C1-Like 1 transporter)

Beyond the preview

Go deeper on gualou + xiebai.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gualou + xiebai.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call